A new commentary in the Georgian Medical Journal identifies three core requirements that must be implemented for all critically ill research participants: independent ethical review, informed consent, and proportional risk–benefit assessment. These safeguards address the heightened vulnerability of severely ill patients whose cognitive function is compromised and who are at elevated risk of therapeutic misconception.
Critically ill patients represent one of medicine’s most vulnerable research populations, facing multiple layers of risk including impaired decision-making capacity, dependency relationships with clinicians, and practical inability to withdraw from studies. The framework clarifies that enrolling such patients without prior ethical approval and legally valid informed consent is impermissible. By establishing these three pillars as mandatory requirements, the commentary ensures that Georgian research governance meets international standards while protecting research participants from exploitation and harm.
Read the full article on GMJ Newsroom.
Was this article helpful?
